This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ADSTILADRIN
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SUO 2024
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Conference Highlights
AUA 2018
AUA 2018
Prostate Cancer
Bladder Cancer
Renal Cancer
Testis & Penile Cancers
Lower Urinary Tract Conditions / Nocturia
GU Reconstruction
Infections & Inflammation
Laparoscopic / Robotic Surgery
Sexual Function
Stone Disease
Press Releases
AUA 2018 Lower Urinary Tract Conditions / Nocturia
Viewing 1-20 of 34 articles
AUA 2018: A Catheter Insertion Force Assessment Tool: Design and Preclinical Results
AUA 2018: Risk Factors Associated with Fecal Incontinence in Patients with Overactive Bladder
AUA 2018: Concomitant Procedures Performed at the Time of Midurethral Sling Affect Post Operative Urinary Retention Rate
AUA 2018: Impact of Lifetime Obesity on Urinary Incontinence in the Women’s Health Initiative
AUA 2018: The Utility of Urodynamic Evaluation in Clinical Practice
AUA 2018: Elevated Post-Void Residual Volumes, Not Associated with Self-Reported Urinary Tract Infections: A Report From The Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN)
AUA 2018: Safety & Efficacy of the eCOIN™ Implantable Tibial Nerve Stimulation Device for Overactive Bladder Syndrome
AUA 2018: No Increased Risk of Clean Intermittent Catheterization with Onabotulinumtoxina Retreatment
AUA 2018: Onabotulinumtoxina Injection to the External Urethral Sphincter for Voiding Dysfunction in Females
AUA 2018: Bladder Neck Artificial Urinary Sphincter for Recurrent or Complex Primary Urodynamically Proven Stress and Mixed Urinary Incontinence
AUA 2018: Relationship Between Excess Visceral Fat Volume and Overactive Bladder
AUA 2018: Contemporary Review of Complications Associated with Autologous Rectus Fascia Pubovaginal Slings
AUA 2018: Efficacy and Safety of Add-on Mirabegron vs Placebo to Tamsulosin in Men with Overactive Bladder Symptoms MATCH Study
AUA 2018: Insomnia Induces Lower Urinary Tract Symptoms: The Natural History and Risk Factors for LUTS from the Nagahama Longitudinal Study
AUA 2018: Extended First Uninterrupted Sleep Period in Elderly Patients Following Treatment with AV002, an Emulsified Low Dose Vasopressin Analog for Nocturia
AUA 2018: The “Metabolic” Overactive Bladder Syndrome
AUA 2018: A Prospective Study to Evaluate Efficacy with the Nuro™ Percutaneous Tibial Neuromodulation System in Drug Naïve Patients with Overactive Bladder Syndrome
AUA 2018: Underactive Bladder: Evaluation and Management
AUA 2018: OAB - Therapeutic Algorithm for Third-Line Therapies: When I Use What, and Why?
AUA 2018: Association Between Overactive Bladder Severity and Bold fMRI Brain Activity
1
2
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free